Executive Summary
Market Research Methodology
2.1. Research methodology and design
2.2. Sample selection
2.3. Reliability and validity
Market Analysis
3.1. Market size and growth rates
3.2. Macroeconomic change
3.3. Market growth drivers, market dynamics and trends
3.4. Megatrends and their impact
3.5. Change and strategic drift
3.6. Characteristics mapping
3.7. Value chain analysis
3.8. Distribution platforms
3.9. Market scenarios and opportunity forecasts
3.10. Geographic analysis
3.11. Relevant markets
3.12. The new frontiers of growth
3.13. Creating value through sustainable strategies
Market Breakdown by Molecule
4.1. Introduction
4.2. Small Molecule
4.3. Large Molecule
4.3.1. LC-MS Studies
4.3.2. Immunoassays
4.3.3. PK
4.3.4. ADA
4.3.5. Others
4.4. Others
Market Breakdown by Test
5.1. Introduction
5.2. ADME
5.2.1. In-Vivo
5.2.2. In-Vitro
5.3. PK
5.4. PD
5.5. Bioavailability
5.6. Bioequivalen
Market Breakdown by Workflow
6.1. Introduction
6.2. Sample Preparation
6.2.1. Protein Precipitation
6.2.2. Liquid-Liquid Extraction
6.2.3. Solid Phase Extraction
6.3. Sample Analysis
6.3.1. Hyphenated technique
6.3.2. Chromatographic technique
6.3.3. Electrophoresis
6.3.4. Ligand Binding Assay
6.3.5. Mass Spectrometry
6.3.6. Nuclear Magnetic Resonance
6.4. Other Workflow Processes
Market Breakdown by Application
7.1. Introduction
7.2. Oncology
7.3. Neurology
7.4. Infectious Diseases
7.5. Gastroenterology
7.6. Cardiology
7.7. Other Applications
Market Breakdown by End Use
8.1. Introduction
8.2. Pharma & BioPharma Companies
8.3. CDMO
8.4. CRO
Market Breakdown by Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2.South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Russia
9.3.5. Italy
9.3.6. Spain
9.3.7. Sweden
9.3.8. Switzerland
9.3.9. Netherlands
9.3.10. Others
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. India
9.4.5. Australia
9.4.6. Others
9.5.Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Israel
9.5.5. Others
Competitive Landscape
10.1. Low-cost position
10.2. Competitive situation and trends
10.3. Competitive strategies
10.4. Marketing strategies
10.5. Industry benchmarking
10.6. Maintaining current market share
10.7. Expansion path
10.8. Recent market and industry developments
10.8.1. New product developments and announcements
10.8.2. Agreements, partnerships, joint ventures, and collaborations
10.8.3. Mergers and acquisitions and major PE deals
Companies Profiled
11.1. Atlasciences
11.2. BioAgilytix Labs
11.3. Celerion
11.4. Charles River Laboratories International
11.5. Covance, Inc.
11.6. Eurofins Scientific
11.7. Frontage Labs
11.8. ICON Plc
11.9. Intertek Group Plc
11.10. IQVIA
11.11. Labcorp (Toxikon)
11.12. Medpace
11.13. Pace Analytical Services LLC
11.14. Parexel International Corporation
11.15. PPD, Inc. (Thermo Fisher Scientific Inc)
11.16. SGS SA
11.17. Syneos Health